• Skip to primary navigation
  • Skip to main content
  • Skip to primary navigation
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Winthrop P. Rockefeller Cancer Institute: Research
  • UAMS Health
  • Jobs
  • Giving
  • About
  • Resources
    • Clinical Trials Office
    • Internal Funding Opportunities
    • Research Training and Education
    • Research Calendar
    • Shared Resources
    • Cancer Clinical Research Pre-Review Approval Process
  • Membership
  • Research Activity
    • Research Programs
    • Clinical Research
    • Public Health Studies
  1. University of Arkansas for Medical Sciences
  2. Winthrop P. Rockefeller Cancer Institute
  3. Research
  4. 2022 Seeds of Science Research Awards

2022 Seeds of Science Research Awards

Presented annually since 2009, the Winthrop P. Rockefeller Cancer Institute Seeds of Science Awards assist cancer researchers in collecting data and developing projects that have the potential to result in significant research findings.

This year we had a record number of applicants and have supported a record number of investigators. These efforts directly support our mission to achieve NCI designation. 

The following four Cancer Institute members will receive $50,000 individual pilot awards: 

Katie Ryan, Ph.D.
Katie Ryan, Ph.D.
Assistant Professor, Department of Biochemistry & Molecular Biology.
A proteomics approach to determining how driver mutations effect the metastatic potential of lung cancer.
Mohammad Alinoor Rahman, Ph.D.
Mohammad Alinoor Rahman, Ph.D.
Assistant Professor, Department of Biochemistry & Molecular Biology.
Understanding and Targeting Aberrant Splicing in MDS-RS.
Michael Bauer. Ph.D.
Michael Bauer, Ph.D.
Assistant Professor, Department of Biomedical Informatics
Mechanism of the novel NEK2 signaling pathways in myeloma progression.
Yong-Chen
Yong-Chen “William” Lu, Ph.D.
Assistant Professor, Department of Pathology
Detecting mitochondrial DNA mutations at the single-cell level.

In addition to supporting novel ideas from individual Cancer Institute members, we also support team science by funding groups of laboratories that join forces to address challenging cancer research questions. The following research teams will receive $100,000 each to support their work. 

$100,000 Team Awards 

Sayem Miah, Ph.D., Mohammad Rahman, Ph.D., and Stephanie Byrum, Ph.D., assistant professors in the Department of Biochemistry and Molecular Biology. Loss of FAM60A promotes HBB induced mammary gland tumorigenesis.

Bolni “Marius” Nagalo, Ph.D., assistant professor in the Department of Pathology, Martin Cannon, Ph.D., professor in the Department of Microbiology and Immunology and Alexei Basnakian, M.D., Ph.D., professor in the Department of Pharmacology & Toxicology. Immunotherapy of hepatocellular carcinoma by live attenuated vaccine vectors.

Samantha Kendrick, Ph.D., assistant professor in the Department of Biochemistry & Molecular Biology and Brendan Frett, Ph.D., assistant professor in the Department of Pharmaceutical Sciences. NEK2 kinase as a new oncogenic vulnerability in lymphoma.

Justin Leung, Ph.D., assistant professor in the Department of Radiation Oncology and Brian Koss, Ph.D., assistant professor in the Department of Biochemistry & Molecular Biology. Functional ORFeome atlas. 

Adam Wolfe, M.D., Ph.D., assistant professor in the Department of Radiation Oncology, Isabelle Racine Miousse, Ph.D., assistant professor in the Department of Biochemistry & Molecular Biology and Nukhet Aykin-Burns, Ph.D., associate professor in the Department of Pharmaceutical Sciences. Synergizing methionine restriction with radiation therapy in KRAS mutant rectal cancer.

Kevin Raney, Ph.D., professor, Eric Enemark, Ph.D., associate professor, Robert Eoff, Ph.D., professor – all in the Department of Biochemistry & Molecular Biology – and Karl Boehme, Ph.D., associate professor in the Department of Microbiology & Immunology. Helicases, Non-Canonical DNA and Their Links to Cancer through Innate Immunity.

Hong-yu Li, Ph.D., professor in the Department of Pharmaceutical Sciences and Zhiqiang Qin, M.D., Ph.D., associate professor in the Department of Pathology. Development of Potent Dual HDACs/BRD4 Inhibitors for the Treatment of Virus-associated Lymphomas.

Posted by Chadley Uekman on May 6, 2022

Filed Under: Research Newsletter

Winthrop P. Rockefeller Cancer Institute LogoWinthrop P. Rockefeller Cancer InstituteWinthrop P. Rockefeller Cancer Institute
Address: 449 Jack Stephens Dr., Little Rock, AR 72205
Parking Deck: 4018 W Capitol Ave, Little Rock, AR 72205
Appointments: (501) 296-1200
Referring Physicians: (501) 686-6080
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy

© 2023 University of Arkansas for Medical Sciences